High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner

Julia K Polansky, Rajia Bahri, Mylene Divivier, Erwin H Duitman, Christina Vock, Diego A Goyeneche-Patino, Zane Orinska, Silvia Bulfone-Paus

    Research output: Contribution to journalArticlepeer-review

    Fingerprint

    Dive into the research topics of 'High dose CD11c-driven IL15 is sufficient to drive NK cell maturation and anti-tumor activity in a trans-presentation independent manner'. Together they form a unique fingerprint.

    Immunology and Microbiology